Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
National Institutes of Health Clinical Center (CC)
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Inmune Bio, Inc.
AbbVie
Center for International Blood and Marrow Transplant Research
Takeda
Emory University
Children's Oncology Group
Cancer Research UK
Center for International Blood and Marrow Transplant Research
AbbVie
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Constellation Pharmaceuticals
PharmaEssentia
AbbVie
Florida International University
M.D. Anderson Cancer Center
Cogent Biosciences, Inc.
Thomas Jefferson University
Hikma Pharmaceuticals LLC
Stanford University
AbbVie
Ann & Robert H Lurie Children's Hospital of Chicago
Taproot Health
GlaxoSmithKline
Takeda
University Health Network, Toronto
University Health Network, Toronto
Amgen
GlaxoSmithKline
Tampere University Hospital
Cancer Support Community, Research and Training Institute, Philadelphia
University of Kansas Medical Center
Northwestern University
AbbVie
Centre Hospitalier Universitaire de Nīmes
AbbVie
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
AbbVie
University of Nebraska
Asana BioSciences
GlaxoSmithKline